These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32796757)

  • 1. Superparamagnetic Iron Oxide Nanoparticles Carrying Chemotherapeutics Improve Drug Efficacy in Monolayer and Spheroid Cell Culture by Enabling Active Accumulation.
    Nguyen K; Nuß B; Mühlberger M; Unterweger H; Friedrich RP; Alexiou C; Janko C
    Nanomaterials (Basel); 2020 Aug; 10(8):. PubMed ID: 32796757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Efficiency of Free and Nanoparticle-Loaded Mitoxantrone for Magnetic Drug Targeting in Multicellular Tumor Spheroids.
    Hornung A; Poettler M; Friedrich RP; Zaloga J; Unterweger H; Lyer S; Nowak J; Odenbach S; Alexiou C; Janko C
    Molecules; 2015 Sep; 20(10):18016-30. PubMed ID: 26437393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids.
    Dinter J; Friedrich RP; Yang H; Pilarsky C; Mangge H; Pöttler M; Janko C; Alexiou C; Lyer S
    Materials (Basel); 2023 Apr; 16(7):. PubMed ID: 37049199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitoxantrone-loaded superparamagnetic iron oxide nanoparticles as drug carriers for cancer therapy: Uptake and toxicity in primary human tubular epithelial cells.
    Cicha I; Scheffler L; Ebenau A; Lyer S; Alexiou C; Goppelt-Struebe M
    Nanotoxicology; 2016; 10(5):557-66. PubMed ID: 26468004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity of Mitoxantrone-loaded Superparamagnetic Iron Oxide Nanoparticles in a HT-29 Tumour Spheroid Model.
    Hornung A; Poettler M; Friedrich RP; Weigel B; Duerr S; Zaloga J; Cicha I; Alexiou C; Janko C
    Anticancer Res; 2016 Jun; 36(6):3093-101. PubMed ID: 27272833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Setup for Determination of Nanoparticle-Mediated Magnetic Cell and Drug Accumulation in Tumor Spheroids under Flow Conditions.
    Behr J; Carnell LR; Stein R; Pfister F; Friedrich B; Huber C; Lyer S; Band J; Schreiber E; Alexiou C; Janko C
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as Platform for the Targeted Multimodal Tumor Therapy.
    Janko C; Ratschker T; Nguyen K; Zschiesche L; Tietze R; Lyer S; Alexiou C
    Front Oncol; 2019; 9():59. PubMed ID: 30815389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the adsorption and desorption of mitoxantrone to lauric acid/albumin coated iron oxide nanoparticles.
    Zaloga J; Feoktystov A; Garamus VM; Karawacka W; Ioffe A; Brückel T; Tietze R; Alexiou C; Lyer S
    Colloids Surf B Biointerfaces; 2018 Jan; 161():18-26. PubMed ID: 29035747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma-targeted superparamagnetic iron oxide nanoparticles as drug-carrying vehicles for theranostic effects.
    Xu HL; Mao KL; Huang YP; Yang JJ; Xu J; Chen PP; Fan ZL; Zou S; Gao ZZ; Yin JY; Xiao J; Lu CT; Zhang BL; Zhao YZ
    Nanoscale; 2016 Aug; 8(29):14222-36. PubMed ID: 27396404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
    Wu VM; Huynh E; Tang S; Uskoković V
    Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone-Loaded Nanoparticles for Magnetically Controlled Tumor Therapy-Induction of Tumor Cell Death, Release of Danger Signals and Activation of Immune Cells.
    Ratschker T; Egenberger L; Alev M; Zschiesche L; Band J; Schreiber E; Frey B; Derer A; Alexiou C; Janko C
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32992645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Tumor Spheroid Reconstitution for Testing Mitochondrial Targeted Magnetic Hyperthermia Treatment.
    Peng X; Wang B; Yang Y; Zhang Y; Liu Y; He Y; Zhang C; Fan H
    ACS Biomater Sci Eng; 2019 Mar; 5(3):1635-1644. PubMed ID: 33405636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic drug targeting reduces the chemotherapeutic burden on circulating leukocytes.
    Janko C; Dürr S; Munoz LE; Lyer S; Chaurio R; Tietze R; Löhneysen Sv; Schorn C; Herrmann M; Alexiou C
    Int J Mol Sci; 2013 Apr; 14(4):7341-55. PubMed ID: 23549268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Enable a Stable Non-Spilling Loading of T Cells and Their Magnetic Accumulation.
    Boosz P; Pfister F; Stein R; Friedrich B; Fester L; Band J; Mühlberger M; Schreiber E; Lyer S; Dudziak D; Alexiou C; Janko C
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of Nanomedicine in Tumor Spheroid as an
    Roy SM; Garg V; Barman S; Ghosh C; Maity AR; Ghosh SK
    Front Bioeng Biotechnol; 2021; 9():785937. PubMed ID: 34926430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-conjugated superparamagnetic iron oxide nanoparticles for imaging of epidermal growth factor receptor-targeted cells and gliomas.
    Mu K; Zhang S; Ai T; Jiang J; Yao Y; Jiang L; Zhou Q; Xiang H; Zhu Y; Yang X; Zhu W
    Mol Imaging; 2015; 14():. PubMed ID: 26044549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications.
    Lin MM; Kim DK; El Haj AJ; Dobson J
    IEEE Trans Nanobioscience; 2008 Dec; 7(4):298-305. PubMed ID: 19203873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.